Journal Title：Cellular Oncology

The Official Journal of the International Society for Cellular Oncology

Focuses on translational research

Addresses the conversion of cell biology to clinical applications

Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions.

A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients.

In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.

國際細胞腫瘤學(xué)會官方期刊

專注于轉(zhuǎn)化研究

致力于將細胞生物學(xué)轉(zhuǎn)化為臨床應(yīng)用

《細胞腫瘤學(xué)》發(fā)表來自各種生物醫(yī)學(xué)和臨床學(xué)科的科學(xué)論文，涉及細胞和組織水平的基礎(chǔ)和轉(zhuǎn)化癌癥研究、該領(lǐng)域的技術(shù)和生物信息學(xué)發(fā)展以及臨床應(yīng)用。這包括各種領(lǐng)域，如基因組技術(shù)、微陣列和其他高通量技術(shù)、基因組不穩(wěn)定性、SNP、DNA甲基化、信號通路、DNA組織、（亞）微觀成像、蛋白質(zhì)組學(xué)、生物信息學(xué)、基因組學(xué)的功能效應(yīng)、藥物設(shè)計和開發(fā)、分子診斷和靶向癌癥治療、基因型-表型相互作用。

主要目標是將這些領(lǐng)域的最新發(fā)展從研究實驗室轉(zhuǎn)化為常規(guī)患者管理。為此，細胞腫瘤學(xué)為分子生物學(xué)家和遺傳學(xué)家、技術(shù)開發(fā)人員、病理學(xué)家、（醫(yī)學(xué)）腫瘤學(xué)家和其他參與癌癥患者管理的臨床醫(yī)生之間建立了一個科學(xué)信息交流平臺。

體外研究優(yōu)先得到具有臨床病理學(xué)關(guān)聯(lián)的腫瘤組織驗證的支持。

Cellular Oncology創(chuàng)刊于2011年，由Springer Netherlands出版商出版，收稿方向涵蓋ONCOLOGY - CELL BIOLOGY全領(lǐng)域，此刊是該細分領(lǐng)域中屬于非常不錯的SCI期刊，在行業(yè)細分領(lǐng)域中學(xué)術(shù)影響力較大，專業(yè)度認可很高，所以對原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 約12月 ，影響因子指數(shù)4.9，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。